Seller record · Telehealth service

GOAL MD

By Peptide Alliance, Editorial publisherRecorded October 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: The treatment, promotion and terms pages describe licensed compounding pharmacies without naming the dispensing facility. 2 more criteria also fail; see the table below.

At a glance

GOAL MDTelehealth service

4/8criteria passed

Price: Printed on its own pages before sign-up
Sells: compounded semaglutide, compounded tirzepatide, sermorelin, and 1 more
FDA letters: None on file

Visit GOAL MD See all eight dispositions

Telehealth service. Passes 4 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth platform with prepaid compounded GLP-1 plans and a separate brand-name physician-care membership, whose billing terms distinguish the two programs.

Operating entity The company, contact, terms and privacy pages identify GOAL MD without printing a separate legal entity name.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	GOAL MD's promotions page; GOAL MD's website
S2	Prescription gating	NOT VERIFIED	GOAL MD's billing cancellation page; GOAL MD's terms and conditions
S3	Pharmacy identification	FAIL	GOAL MD's promotions page; GOAL MD's terms and conditions; GOAL MD's sermorelin product page
S4	Compounding disclosure	PASS	GOAL MD's promotions page; GOAL MD's answers page
S5	Analytical documentation	FAIL	GOAL MD's sermorelin product page; GOAL MD's promotions page
S6	Business address	FAIL	GOAL MD's contact page; GOAL MD's terms and conditions; GOAL MD's privacy policy
S7	Price disclosure	PASS	GOAL MD's website; GOAL MD's promotions page; GOAL MD's terms and conditions
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA physician reviews the health intake and confirms the appropriate medication and treatment plan.Source: GOAL MD's promotions page; GOAL MD's website.

S2NOT VERIFIEDThe payment-sequence question did not resolve from the published material. The billing policy says the initial payment covers consultation, physician evaluation and medication, and the terms say physician review begins after payment. The public pages do not establish whether a medical assessment is completed before that charge. The check is open.Source: GOAL MD's billing cancellation page; GOAL MD's terms and conditions.

S3FAILThe treatment, promotion and terms pages describe licensed compounding pharmacies without naming the dispensing facility.Source: GOAL MD's promotions page; GOAL MD's terms and conditions; GOAL MD's sermorelin product page.

S4PASSThe promotions and answer pages explicitly state that compounded medications are not FDA-approved and distinguish them from approved finished drugs.Source: GOAL MD's promotions page; GOAL MD's answers page.

S5FAILThe sermorelin page claims lot sterility testing but provides no reachable certificate of analysis or lot document. The GLP-1 pages also publish no such document.Source: GOAL MD's sermorelin product page; GOAL MD's promotions page.

S6FAILThe contact, terms and privacy pages provide telephone and email support without publishing a physical business address.Source: GOAL MD's contact page; GOAL MD's terms and conditions; GOAL MD's privacy policy.

S7PASSThe home page lists semaglutide at $99 a month on a twelve-month prepaid plan totaling $1,188. Promotions list tirzepatide at $159 a month prepaid for twelve months or $249 month-to-month. The separate brand-name access membership charges for physician supervision rather than medication.Source: GOAL MD's website; GOAL MD's promotions page; GOAL MD's terms and conditions.

S8PASSNo FDA warning letter names GOAL MD, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, sermorelin, NAD+.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide Who sells sermorelin Who sells NAD+

Visit GOAL MD

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.